Group items tagged

The main growth driver for personal accident and health insurance during 2008 to 2012 was the launch of HIV or AIDS insurance by both health and life insurers, which was purchased by a large number of the country's formerly uninsured population. The personal accident and health insurance segment grew at a CAGR of 10.7% during 2008 to 2012. This robust growth was supported by the country's increasing per capita income levels, GDP growth, favorable insurance reforms, and financial and healthcare service expansions.

The South Korean pharmaceutical industry is highly fragmented, with almost all the domestic pharmaceutical companies having a strong portfolio of generic products rather than expensive, branded drugs. An increase in insurance coverage, an ageing population and favorable government initiatives are expected to drive future growth in the pharmaceutical industry in South Korea. Improved intellectual property rights, changing demographics and government support have contributed towards making the South Korean pharmaceutical industry attractive for MNCs.

Taiwan's pharmaceutical market was worth USD 4.4 billion in 2012 having grown at a CAGR of 2.9%. It is estimated to reach USD 5.5 billion by 2018, growing at a CAGR of 3.9%. Although the size of the market is small compared with other growing markets in Asia, it is expected to provide a market entry point for companies wishing to launch their products in other larger markets.